Journal
DIGESTIVE DISEASES AND SCIENCES
Volume 63, Issue 2, Pages 312-320Publisher
SPRINGER
DOI: 10.1007/s10620-017-4887-1
Keywords
Fibrosis; Reactive oxygen species (ROS); Nuclear factor-erythroid-2-related factor 2 (NF-E2-related factor); Nrf2; Antioxidant response element (ARE); TGF-beta 1/Smad pathway; miRNA; Inflammatory bowel disease (IBD); Crohn's disease; Colitis
Categories
Ask authors/readers for more resources
Intestinal fibrosis, a common complication of inflammatory bowel diseases, becomes clinically apparent in similar to 40% of patients with Crohn's disease and similar to 5% of those with ulcerative colitis. Fibrosis, a consequence of local chronic inflammation, is characterized by excessive deposition of extracellular matrix (ECM) proteins by activated myofibroblasts, which are modulated by pro-fibrotic and anti-fibrotic factors. Fibrosis depends on the balance between production and degradation of ECM proteins. Although the transforming growth factor (TGF)-beta 1/Smad pathway is the major driving force of fibrosis, several pro-fibrogenic and anti-fibrogenic endogenous factors appear to interact directly with this pathway such as reactive oxygen species (ROS) and nuclear factor-erythroid 2-related factor 2 (Nrf2), which are connected with TGF-beta 1 during fibrosis development in several organs, including the intestine. Nrf2 is a ubiquitous master transcription factor that upregulates the expression of antioxidant enzymes and cytoprotective proteins mediated by antioxidant response elements (AREs). Here, I describe and discuss the links among TGF-beta 1, ROS, and Nrf2-AREs in the pathogenesis of intestinal fibrosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available